Baseline | Procedure | Discharge | 30 days (24-45) | 3 months (84-105)(84-105) | 6 months (174-195) | 1 year (335-395) | 2 years (700-790) | 3 years (1065-1125) | 4 years (1430-1490) | 5 years (1795-1855) | Unsched | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | X | |||||||||||
Medical History | ||||||||||||
Physical Exam | X | X | X | X | X | X | X | |||||
Concomitant Meds | ||||||||||||
Anticoagulant/antiplatelet therapy | X1 | X2 | X | X | ||||||||
Informed Consent | X | |||||||||||
Incl/Excl Evaluation | X | X | ||||||||||
Routine Lab testing (see Table 2) | X3 | X | X | X | X | X | X | |||||
Ankle pressure, toe pressure, TcPO2, PVR (at least 1 required) and brachial pressure | X3 | X | X | X | X | X | X | |||||
Wound assessment7 and Wound Care | X | X8 | X | X | X | X | X | |||||
Rutherford Staging | X | X | X | X | X | X | ||||||
EQ5D | X3 | X | X | X | X | |||||||
WIQ | X | X | X | X | ||||||||
Angiography | X3 | X | X4 | X5 | ||||||||
Hospital FU Visits | X | X | X | X | ||||||||
Telephone FU | X | X | X | X | ||||||||
Adverse Event Assessment | X | X | X | X6 | X | X | X | X6 | X6 | X6 | X |